참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Aminoguanidine | HCID 2146 | — |
| 반응물 | Diethyl (ethoxymethylene)malonate | HCID 6871 | — |
| 반응물 | 1,2,3-Thiadiazole | HCID 67518 | — |
| 반응물 | (4-Morpholinyl)acetic acid trifluoroacetic acid salt | HCID 69732510 | — |
| 생성물 | [1,2,3]Thiadiazolo[5,4-d]pyrimidine | HCID 45080540 | — |
반응 단계
5-Hydroxy-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-carboxamides. As described in Chart BL, (4-morpholinyl)acetic acid trifluoroacetic acid salt BL.1 (J. Med. Chem. 1994, 37, 4538-4554) is cyclized to the thiadiazole BL.2 with aminoguanidine in polyphosphoric acid. Condensation of BL.2 with diethyl ethoxymethylenemalonate followed by thermal cyclization affords thiadiazolopyrimidine BL.3. The resulting ester BL.3 is then saponified to afford the corresponding acid BL.4 which is then coupled with a benzylamine (e.g. 4-chlorobenzylamine) mediated by 1,1′-carbonyldiimidazole (or other suitable carboxylic acid activating agent) to provide amides of the general formula BL.5. A specific example of heterocycle W19.2 in which R8=OH is also prepared as described in Chart BL. Thiadiazole BL.2 is heated in xylenes with diethyl 2-(((4-chlorobenzyl)amino)carbonyl)malonate (prepared by the reaction of 4-chlorobenzylamine with triethyl methanetricarboxylate) to afford thiadiazolopyrimidine BL.6.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06903097B2 |
|---|
| 출처 데이터셋 | uspto-grants-2005_06 |
|---|
| ORD ID | ord-e0b8b46c4f1c47d6a76a2bff9286f9c8 |
|---|
| 출처 메모 | uspto-grants-2005_06 |
|---|